Alterity Therapeutics (PRAN) News Today → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free PRAN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKazia Therapeutics Limited (KZIA)finance.yahoo.com - April 18 at 4:07 AMAlterity Therapeutics Says Phillip Hains To Replace Kathryn Andrews As CFOnasdaq.com - December 21 at 9:03 AMAlterity Therapeutics Appoints Phillip Hains as Chief Financial Officermarkets.businessinsider.com - December 21 at 9:03 AMAlterity jumps after promising data on Parkinson's candidateseekingalpha.com - December 4 at 11:27 PMWhy Is Alterity Therapeutics (ATHE) Stock Up 150% Today?investorplace.com - December 4 at 3:08 PMAxsome Therapeutics Inc AXSMmorningstar.com - October 31 at 1:36 AMADRs End Higher; Orchard Therapeutics PLC Climbs 96%morningstar.com - October 8 at 12:03 AMAlterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson's and Alzheimer'stechnews.tmcnet.com - August 23 at 7:52 AMAlterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer's Diseasetechnews.tmcnet.com - March 14 at 10:02 AMAlterity: Study Shows ATH434 Prevents Loss of Brain Cells in Parkinson's Disease Animal Modelmarketwatch.com - January 30 at 2:24 PMAlterity Therapeutics Stock (OTC:PRNAF), Analyst Ratings, Price Targets, Predictionsbenzinga.com - September 26 at 11:44 PMHere's Why Alterity Therapeutics Shares Are Volatilemsn.com - September 20 at 1:16 PM Get Alterity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAN and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. PRAN Media Mentions By Week PRAN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAN News Sentiment▼0.000.39▲Average Medical News Sentiment PRAN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAN Articles This Week▼00▲PRAN Articles Average Week Get Alterity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Galecto News Today Aptorum Group News Today Indaptus Therapeutics News Today NeuroSense Therapeutics News Today KALA BIO News Today BioVie News Today Vincerx Pharma News Today Avalo Therapeutics News Today Talphera News Today Sol-Gel Technologies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAN) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsBiden replacement revealed?Paradigm PressThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaCould Your Accounts Be Frozen?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.